2017
DOI: 10.1016/j.ejmp.2017.10.064
|View full text |Cite
|
Sign up to set email alerts
|

39. First implementation in France of nonpalpable breast lesions localization using an 125 I-seed (radioactive)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…But in France, the gold standard technique remains implanting a metal wire from the lesion to the skin. The Antoine Lacassagne Centre (Nice, France) is the first French hospital authorised to offer an alternative solution with an iodine-125-seed ( 125 I-seed) implanted into the tumour [6]. The two techniques are currently compared within the randomised prospective clinical trial "IODINE BREAST" (NCT02759133).…”
Section: Introductionmentioning
confidence: 99%
“…But in France, the gold standard technique remains implanting a metal wire from the lesion to the skin. The Antoine Lacassagne Centre (Nice, France) is the first French hospital authorised to offer an alternative solution with an iodine-125-seed ( 125 I-seed) implanted into the tumour [6]. The two techniques are currently compared within the randomised prospective clinical trial "IODINE BREAST" (NCT02759133).…”
Section: Introductionmentioning
confidence: 99%